Bio-Rad Laboratories Inc (BIO) is a Healthcare · Medical Devices company listed on NYSE. Price $376.41 (-1.57%), Market cap $6.96B, P/E ratio 42.76, 52-week low–high $216.56 ~ $339.75.
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment se
Financial statements, price targets, institutional (13F) holdings and related news for Bio-Rad Laboratories Inc are updated in real time on BlackAll Trade.
Bio-Rad Laboratories Inc trades at $376.41 (-1.57%). Real-time quotes and charts are available on BlackAll Trade.
Bio-Rad Laboratories Inc has a market cap of about $6.96B. Its P/E ratio is 42.76.
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally